Effect of Danggui Shaoyao Powder on mice model with non-alcoholic fatty liver induced by high-fat diet

Kaishun SHI; Zheng XU; Yuebing YUE; Jie HUANG

doi:10.16305/j.1007-1334.2021.2011143

您当前的位置：

首页 >

文章列表页 >

Effect of Danggui Shaoyao Powder on mice model with non-alcoholic fatty liver induced by high-fat diet

更新时间：2022-08-03

- Effect of Danggui Shaoyao Powder on mice model with non-alcoholic fatty liver induced by high-fat diet
- Shanghai Journal of Traditional Chinese Medicine Vol. 55, Issue 9, Pages: 81-85(2021)
- 作者机构：
  
  1.浙江中医药大学附属第二医院老年科（浙江　杭州　310005）
- 作者简介：
- 基金信息：
- DOI：10.16305/j.1007-1334.2021.2011143
  CLC：
扫描看全文
Kaishun SHI, Zheng XU, Yuebing YUE, et al. Effect of Danggui Shaoyao Powder on mice model with non-alcoholic fatty liver induced by high-fat diet. [J]. Shanghai Journal of Traditional Chinese Medicine 55(9):81-85(2021)
DOI：

Kaishun SHI, Zheng XU, Yuebing YUE, et al. Effect of Danggui Shaoyao Powder on mice model with non-alcoholic fatty liver induced by high-fat diet. [J]. Shanghai Journal of Traditional Chinese Medicine 55(9):81-85(2021) DOI： 10.16305/j.1007-1334.2021.2011143.

摘要

目的,2,观察当归芍药散对非酒精性脂肪肝小鼠模型肝功能、肝脏和血清三酰甘油（TG）水平以及肝组织形态学的影响。,方法,2,雄性小鼠40只，随机分为正常组10只及高脂高糖造模组30只。造模成功后将高脂高糖组小鼠随机分为模型组、当归芍药散组和奥贝胆酸对照组。当归芍药散组（25.8 g/kg）和奥贝胆酸对照组（0.6 mg/kg）均灌胃给予相应的药物，正常组与模型组小鼠以等量饮用水灌胃，各组均于6周后取材。测定各组小鼠的体质量、肝湿重、肝脏和血清三酰甘油水平，血清空腹胰岛素（FINS）含量、空腹血糖（FBG）含量、胰岛素抵抗指数（HOMA-IR），血清ALT、AST水平，肝组织病理及肝组织NAS评分。,结果,2,与模型组比较，当归芍药散组小鼠体质量、肝湿重显著降低（,P,<,0.01），肝脏和血清TG水平显著降低（,P,<,0.01），血清ALT、AST活性均大幅下降（,P,<,0.01），血清FBG、FINS和HOMA-IR均显著降低（,P,<,0.01），肝组织NAS总分显著下降（,P,<,0.01）。,结论,2,当归芍药散可有效抑制小鼠肝脏脂肪沉积，减轻小鼠肝脏炎症损伤。

Abstract

Objective,2,To observe the effect of Danggui Shaoyao Powder on liver function, liver and serum triglyceride (TG) and liver histomorphology of non-alcoholic fatty liver mice.,Methods,2,Forty male mice were randomly divided into normal diet group (,n,=10) and hyperlipidemia-hyperglycemia group (,n,=30). After the successful establishment of the model, the mice in the hyperlipidemia-hyperglycemia group were randomly divided into model group, Danggui Shaoyao Powder group and obeticholic acid group. The mice in the Danggui Shaoyao Powder group (25.8 g/kg) and the obeticholic acid group (0.6 mg/kg) were given the corresponding drugs by intragastric administration. The mice in the normal group and the model group were fed with the same amount of drinking water. The samples were taken after 6 weeks. The body weight, liver wet weight, liver and serum triacylglycerol levels, fasting insulin (FINS) content, fasting blood glucose (FBG) content, insulin resistance index (HOMA-IR), serum ALT and AST levels, liver histopathology and liver tissue NAS score were measured.,Results,2,Compared with the model group, the body weight and wet weight of the liver, the levels of TG in the liver and serum, the activities of ALT and AST in serum, FBG, FINS and HOMA-IR in serum, and the total score of NAS in the liver tissue in Danggui Shaoyao Powder group were significantly lower than those in model group (,P,<,0.01).,Conclusion,2,Danggui Shaoyao Powder can effectively inhibit liver fat deposition and reduce liver inflammatory injury in mice.

关键词

当归芍药散非酒精性脂肪肝模型小鼠血脂中药研究

Keywords

Danggui Shaoyao Powdernon-alcoholic fatty livermodel miceblood lipidstraditional Chinese herbal medicine research

references

ELHENCE A, SHALIMAR . Treatment of non-alcoholic fatty liver disease-current perspectives[J/OL]. Indian J Gastroenterol, 2020[2020-10-15]. http://link.springer.com/article/10.1007%2Fs12664-020-01021-2http://link.springer.com/article/10.1007%2Fs12664-020-01021-2.

贾文燕，包桂篮. 当归芍药散加味合穴位埋线治疗非酒精性脂肪肝40例[J]. 光明中医，2020, 35(16): 2479-2481.

万小雨，曾俊豪，张婉怡，等. 非酒精性脂肪性肝炎小鼠模型的建立[J]. 中国免疫学杂志，2020, 36(16): 1925-1930.

黄继汉，黄晓晖，陈志扬，等. 药理试验中动物间和动物与人体间的等效剂量换算[J]. 中国临床药理学与治疗学，2004, 9(9): 1069-1072.

周雨，张智伟，王京奇. 从“二次打击”学说探讨中药防治非酒精性脂肪肝的研究进展[J].中医药导报，2017, 23(18): 109-111.

帖彦清，张明明，李静，等. 不同类型脂肪肝患者血清HMGB1水平与氧化应激及炎性反应的关系[J]. 河北医药，2018, 40(6): 833-836.

安慎富，杨娅娟，燕飞. 中西医结合治疗非酒精性脂肪肝疗效观察[J]. 山西中医，2019, 35(1): 21-22.

王慧丽，贾淑亚. 当归芍药散合枳术丸治疗非酒精性脂肪性肝病（肝郁脾虚型）临床观察[J]. 现代中医临床，2019, 26(2): 48-51.

赵大鹏，唐宇，初贺明，等. 李延运用疏肝化瘀法辨治特发性水肿经验[J]. 上海中医药杂志，2020, 54(3): 39-41.

高艳琼，延华，金瑞瑞. 泽泻汤治疗高脂血症的临床疗效观察[J]. 西部中医药，2015, 28(9): 88-90.

曹慧. 当归六黄汤抗胰岛素抵抗、脂肪肝和肝纤维化的作用及机制研究[D]. 武汉：华中科技大学，2018.

孙晓琪. 加味泽泻汤对NAFLD小鼠肠道微生物干预作用的研究[D]. 南京：南京中医药大学，2015.

Views

954

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Experimental study on capsaicin improving liver damage in mice with alcoholic liver disease by protecting intestinal mucosal barrier

Mechanism of reversal of adriamycin-resistant hepatocellular carcinoma with ethanol extracts of Oldenlandia diffusa roxb and Scutellariae barbatae herba

Effect of self-made Yiqi Huayu Bushen Recipe on β-catenin signaling pathway in mice with knee osteoarthritis

Effects of Xinqian Ganjie Decoction on lncRNA SNHG16， EGFR and MUC5AC mRNA expression in chronic rhinosinusitis mice

Mechanism of Yucan Granules improving podocyte damage and treating diabetic nephropathy

Related Author

No data

Related Institution

Hepatology Laboratory， Department of Infectious Diseases， Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Central Laboratory， Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Department of Pathology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine

Department of Orthopedics, Xiaoshan TCM Hospital Medicine

Institute of Spine, Longhua Hospital, Shanghai University of Traditional Chinese Medicine

⁰